Mahant, A., Saubi, N., Eto, Y., Guitart, N., Gatell, J. M., Hanke, T., & Joseph, J. (2017). Preclinical development of BCG.HIVA(2auxo.int), harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity. Hum Vaccin Immunother.

Mahant, Aakash, Narcís Saubi, Yoshiki Eto, Núria Guitart, Josep Ma Gatell, Tomáš Hanke, und Joan Joseph. "Preclinical Development of BCG.HIVA(2auxo.int), Harboring an Integrative Expression Vector, for a HIV-TB Pediatric Vaccine. Enhancement of Stability and Specific HIV-1 T-cell Immunity." Hum Vaccin Immunother 2017.

Mahant, Aakash, et al. "Preclinical Development of BCG.HIVA(2auxo.int), Harboring an Integrative Expression Vector, for a HIV-TB Pediatric Vaccine. Enhancement of Stability and Specific HIV-1 T-cell Immunity." Hum Vaccin Immunother 2017.